Hookipa Pharma Inc (HOOK) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.15 (+0.88%), Market cap $0.01B, 52-week low–high $0.82 ~ $1.61.
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology pipeline includes HB-700, a novel next-generation multi-KRAS mutant-targeting investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal, and pancreatic cancers; Eseba-vec, an investigational immunotherapeutic agent in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers with enrollment completed in a Phase 1/2 clinical trial; and HB-300, which targets self-antigens for the treatment of prostate cancer.
Financial statements, price targets, institutional (13F) holdings and related news for Hookipa Pharma Inc are updated in real time on BlackAll Trade.
Hookipa Pharma Inc trades at $1.15 (+0.88%). Real-time quotes and charts are available on BlackAll Trade.
Hookipa Pharma Inc has a market cap of about $0.01B.
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunetherapeutics targeting infectious diseases based on its proprietary arenavirus platform. The company's immuno-oncology p